{"id": "article-27365_0", "title": "Pediatric Pneumonia -- Continuing Education Activity", "content": "Globally, pneumonia is a leading cause of morbidity and mortality in children younger than the age of 5 years. Although the majority of deaths attributed to pneumonia in children are mostly in the developing world, the burden of disease is substantial, and there are significant healthcare-associated costs related to pneumonia in the developed world. This activity reviews the cause, pathophysiology, and presentation of pediatric pneumonia and highlights the role of the interprofessional team in its management.", "contents": "Pediatric Pneumonia -- Continuing Education Activity. Globally, pneumonia is a leading cause of morbidity and mortality in children younger than the age of 5 years. Although the majority of deaths attributed to pneumonia in children are mostly in the developing world, the burden of disease is substantial, and there are significant healthcare-associated costs related to pneumonia in the developed world. This activity reviews the cause, pathophysiology, and presentation of pediatric pneumonia and highlights the role of the interprofessional team in its management."}
{"id": "article-27365_1", "title": "Pediatric Pneumonia -- Continuing Education Activity", "content": "Objectives: Identify the etiology of pediatric pneumonia. Review the presentation of pediatric pneumonia. Outline the treatment and management options available for pediatric pneumonia. Describe interprofessional team strategies for improving care coordination and outcomes in pediatric patients with pneumonia. Access free multiple choice questions on this topic.", "contents": "Pediatric Pneumonia -- Continuing Education Activity. Objectives: Identify the etiology of pediatric pneumonia. Review the presentation of pediatric pneumonia. Outline the treatment and management options available for pediatric pneumonia. Describe interprofessional team strategies for improving care coordination and outcomes in pediatric patients with pneumonia. Access free multiple choice questions on this topic."}
{"id": "article-27365_2", "title": "Pediatric Pneumonia -- Introduction", "content": "Globally, pneumonia is a leading cause of morbidity and mortality in children younger than the age of 5 years. [1] Although the majority of deaths attributed to pneumonia in children are mostly in the developing world, the burden of disease is substantial, and there are significant healthcare-associated\u00a0costs related to pneumonia in the developed world. [2]", "contents": "Pediatric Pneumonia -- Introduction. Globally, pneumonia is a leading cause of morbidity and mortality in children younger than the age of 5 years. [1] Although the majority of deaths attributed to pneumonia in children are mostly in the developing world, the burden of disease is substantial, and there are significant healthcare-associated\u00a0costs related to pneumonia in the developed world. [2]"}
{"id": "article-27365_3", "title": "Pediatric Pneumonia -- Etiology", "content": "The etiology of pneumonia in the pediatric population can be classified by age-specific versus pathogen-specific organisms. [3] Neonates are at risk for bacterial pathogens present in the birth canal, and this includes organisms such as group B streptococci, Klebsiella, Escherichia coli, and Listeria monocytogenes . [4] [5] [6] Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus can be identified in late-onset neonatal pneumonia. [4] Viruses are the main cause of pneumonia in older infants and toddlers between 30 days and 2 years old. [7] In children 2 to 5 years old, respiratory viruses are also the most common. [8] [9] The rise of cases related to S. pneumoniae\u00a0and H. influenzae type B\u00a0is observed in this age group. [10] [11] Mycoplasma pneumonia frequently occurs in children in the range from 5 to 13 years old [12] [13] ;\u00a0however, S. pneumoniae is still the most commonly identified organism. [8] Adolescents usually have the same infectious risks as adults. It is important to consider tuberculosis (TB) in immigrants from high prevalence areas, and children with known exposures. Children with chronic diseases are also at risk for specific pathogens. In cystic fibrosis, pneumonia secondary to S. aureus and Pseudomonas aeruginosa is ubiquitous. [14] Patients with sickle cell disease are at risk of infection from encapsulated organisms. [15] Children who are immunocompromised should\u00a0be\u00a0evaluated for Pneumocystis jirovecii , cytomegalovirus, and fungal species if no other organism is identified. [16] Unvaccinated children are at risk for vaccine-preventable pathogens.", "contents": "Pediatric Pneumonia -- Etiology. The etiology of pneumonia in the pediatric population can be classified by age-specific versus pathogen-specific organisms. [3] Neonates are at risk for bacterial pathogens present in the birth canal, and this includes organisms such as group B streptococci, Klebsiella, Escherichia coli, and Listeria monocytogenes . [4] [5] [6] Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus can be identified in late-onset neonatal pneumonia. [4] Viruses are the main cause of pneumonia in older infants and toddlers between 30 days and 2 years old. [7] In children 2 to 5 years old, respiratory viruses are also the most common. [8] [9] The rise of cases related to S. pneumoniae\u00a0and H. influenzae type B\u00a0is observed in this age group. [10] [11] Mycoplasma pneumonia frequently occurs in children in the range from 5 to 13 years old [12] [13] ;\u00a0however, S. pneumoniae is still the most commonly identified organism. [8] Adolescents usually have the same infectious risks as adults. It is important to consider tuberculosis (TB) in immigrants from high prevalence areas, and children with known exposures. Children with chronic diseases are also at risk for specific pathogens. In cystic fibrosis, pneumonia secondary to S. aureus and Pseudomonas aeruginosa is ubiquitous. [14] Patients with sickle cell disease are at risk of infection from encapsulated organisms. [15] Children who are immunocompromised should\u00a0be\u00a0evaluated for Pneumocystis jirovecii , cytomegalovirus, and fungal species if no other organism is identified. [16] Unvaccinated children are at risk for vaccine-preventable pathogens."}
{"id": "article-27365_4", "title": "Pediatric Pneumonia -- Epidemiology", "content": "There are an estimated 120 million cases of pneumonia annually worldwide, resulting in as many as\u00a01.3 million deaths. [3] Younger children under the age of 2 in the developing world, account for nearly 80% of pediatric deaths secondary to pneumonia. [17] The prognosis of pneumonia is better in the developed world, with fewer lives claimed, but the burden of disease is extreme, with roughly 2.5 million cases yearly.\u00a0Approximately a third to half of these cases lead to hospitalizations. [18] The introduction of the pneumococcal vaccine has significantly lowered the risk of pneumonia in the United States.", "contents": "Pediatric Pneumonia -- Epidemiology. There are an estimated 120 million cases of pneumonia annually worldwide, resulting in as many as\u00a01.3 million deaths. [3] Younger children under the age of 2 in the developing world, account for nearly 80% of pediatric deaths secondary to pneumonia. [17] The prognosis of pneumonia is better in the developed world, with fewer lives claimed, but the burden of disease is extreme, with roughly 2.5 million cases yearly.\u00a0Approximately a third to half of these cases lead to hospitalizations. [18] The introduction of the pneumococcal vaccine has significantly lowered the risk of pneumonia in the United States."}
{"id": "article-27365_5", "title": "Pediatric Pneumonia -- Pathophysiology", "content": "Pneumonia is an invasion of the lower respiratory tract, below the larynx by pathogens either by inhalation, aspiration, respiratory epithelium invasion, or hematogenous spread. [19] There are barriers to infection that include anatomical structures (nasal hairs, turbinates, epiglottis, cilia), and humoral and cellular immunity. [19] Once these barriers are breached, infection, either by fomite/droplet spread (mostly viruses) or nasopharyngeal colonization (mostly bacterial), results in inflammation and injury or death of surrounding epithelium and alveoli. This is ultimately accompanied by a migration of inflammatory cells to the site of infection, causing an exudative process, which in turn\u00a0impairs oxygenation. [20] In the majority of cases, the microbe is not identified, and the most common cause is of viral etiology.", "contents": "Pediatric Pneumonia -- Pathophysiology. Pneumonia is an invasion of the lower respiratory tract, below the larynx by pathogens either by inhalation, aspiration, respiratory epithelium invasion, or hematogenous spread. [19] There are barriers to infection that include anatomical structures (nasal hairs, turbinates, epiglottis, cilia), and humoral and cellular immunity. [19] Once these barriers are breached, infection, either by fomite/droplet spread (mostly viruses) or nasopharyngeal colonization (mostly bacterial), results in inflammation and injury or death of surrounding epithelium and alveoli. This is ultimately accompanied by a migration of inflammatory cells to the site of infection, causing an exudative process, which in turn\u00a0impairs oxygenation. [20] In the majority of cases, the microbe is not identified, and the most common cause is of viral etiology."}
{"id": "article-27365_6", "title": "Pediatric Pneumonia -- Pathophysiology", "content": "There are four stages of lobar pneumonia.\u00a0The first stage occurs within 24 hours and is characterized by alveolar edema and vascular congestion. Both bacteria and neutrophils are present.", "contents": "Pediatric Pneumonia -- Pathophysiology. There are four stages of lobar pneumonia.\u00a0The first stage occurs within 24 hours and is characterized by alveolar edema and vascular congestion. Both bacteria and neutrophils are present."}
{"id": "article-27365_7", "title": "Pediatric Pneumonia -- Pathophysiology", "content": "Red hepatization is the second stage, and it has the consistency of the liver. The stage is characterized by neutrophils, red blood cells, and desquamated epithelial cells. Fibrin deposits in the alveoli are common. The third stage of gray hepatization stage occurs 2-3 days later, and the lung appears dark brown. There is an accumulation of hemosiderin and hemolysis of red cells.", "contents": "Pediatric Pneumonia -- Pathophysiology. Red hepatization is the second stage, and it has the consistency of the liver. The stage is characterized by neutrophils, red blood cells, and desquamated epithelial cells. Fibrin deposits in the alveoli are common. The third stage of gray hepatization stage occurs 2-3 days later, and the lung appears dark brown. There is an accumulation of hemosiderin and hemolysis of red cells."}
{"id": "article-27365_8", "title": "Pediatric Pneumonia -- Pathophysiology", "content": "The fourth stage is the resolution stage, where the cellula infiltrates is resorbed, and the pulmonary architecture is restored. If the healing is not ideal, then it may lead to parapneumonic effusions and pleural adhesions. In bronchopneumonia, there is often patch consolidation of one or more lobes. The neutrophilic infiltrate is chiefly around the center of the bronchi.", "contents": "Pediatric Pneumonia -- Pathophysiology. The fourth stage is the resolution stage, where the cellula infiltrates is resorbed, and the pulmonary architecture is restored. If the healing is not ideal, then it may lead to parapneumonic effusions and pleural adhesions. In bronchopneumonia, there is often patch consolidation of one or more lobes. The neutrophilic infiltrate is chiefly around the center of the bronchi."}
{"id": "article-27365_9", "title": "Pediatric Pneumonia -- History and Physical", "content": "In many cases, complaints associated with pneumonia are nonspecific, including cough, fever, tachypnea, and difficulty breathing. [21] Young children may present with abdominal pain. Important history to obtain includes the duration of symptoms, exposures, travel, sick contacts, baseline health of the child, chronic diseases, recurrent symptoms, choking, immunization history, maternal health, or birth complications in neonates. [22]", "contents": "Pediatric Pneumonia -- History and Physical. In many cases, complaints associated with pneumonia are nonspecific, including cough, fever, tachypnea, and difficulty breathing. [21] Young children may present with abdominal pain. Important history to obtain includes the duration of symptoms, exposures, travel, sick contacts, baseline health of the child, chronic diseases, recurrent symptoms, choking, immunization history, maternal health, or birth complications in neonates. [22]"}
{"id": "article-27365_10", "title": "Pediatric Pneumonia -- History and Physical", "content": "Physical exam should include observation for signs of respiratory distress, including tachypnea, nasal flaring, lower chest in-drawing, or hypoxia on room air. [21] Note that infants may present with reported inability to tolerate feeds, with grunting or apnea. Auscultation for rales or rhonchi in all lung fields with the appropriately sized stethoscope can also aid in diagnosis. In the developed world, other adjuncts like laboratory testing and imaging can be a helpful part of the physical exam. No isolated physical exam finding can accurately diagnose pneumonia. [23] However, the combination of symptoms, including fever, tachypnea, focal crackles, and decreased breath sounds together, raises the sensitivity for finding pneumonia on x-ray. [23] Pneumonia is a clinical diagnosis that should take into consideration the history of present illness, physical exam findings, adjunct testing, and imaging modalities.", "contents": "Pediatric Pneumonia -- History and Physical. Physical exam should include observation for signs of respiratory distress, including tachypnea, nasal flaring, lower chest in-drawing, or hypoxia on room air. [21] Note that infants may present with reported inability to tolerate feeds, with grunting or apnea. Auscultation for rales or rhonchi in all lung fields with the appropriately sized stethoscope can also aid in diagnosis. In the developed world, other adjuncts like laboratory testing and imaging can be a helpful part of the physical exam. No isolated physical exam finding can accurately diagnose pneumonia. [23] However, the combination of symptoms, including fever, tachypnea, focal crackles, and decreased breath sounds together, raises the sensitivity for finding pneumonia on x-ray. [23] Pneumonia is a clinical diagnosis that should take into consideration the history of present illness, physical exam findings, adjunct testing, and imaging modalities."}
{"id": "article-27365_11", "title": "Pediatric Pneumonia -- Evaluation", "content": "Laboratory evaluation in children suspected of having pneumonia should ideally start with non-invasive, rapid bedside testing including nasopharyngeal swab assays for influenza, respiratory syncytial virus, and human metapneumovirus when available and appropriate. This can help minimize unnecessary imaging and antibiotic treatment in children with influenza or bronchiolitis. Children who present with severe disease and appear toxic should have complete blood count (CBC), electrolytes, renal/hepatic function testing, and blood cultures performed. [24] These tests are generally not required in children who present with mild disease. Inflammatory markers do\u00a0not help distinguish between viral and bacterial pneumonia in the pediatric population. [24] [25] However, these tests may be obtained to trend disease progression and serve as prognostic indicators. Children who have been in areas endemic to TB, or have exposure history, and present with signs and symptoms suspicious for pneumonia should have sputum samples or gastric aspirates collected for culture.", "contents": "Pediatric Pneumonia -- Evaluation. Laboratory evaluation in children suspected of having pneumonia should ideally start with non-invasive, rapid bedside testing including nasopharyngeal swab assays for influenza, respiratory syncytial virus, and human metapneumovirus when available and appropriate. This can help minimize unnecessary imaging and antibiotic treatment in children with influenza or bronchiolitis. Children who present with severe disease and appear toxic should have complete blood count (CBC), electrolytes, renal/hepatic function testing, and blood cultures performed. [24] These tests are generally not required in children who present with mild disease. Inflammatory markers do\u00a0not help distinguish between viral and bacterial pneumonia in the pediatric population. [24] [25] However, these tests may be obtained to trend disease progression and serve as prognostic indicators. Children who have been in areas endemic to TB, or have exposure history, and present with signs and symptoms suspicious for pneumonia should have sputum samples or gastric aspirates collected for culture."}
{"id": "article-27365_12", "title": "Pediatric Pneumonia -- Evaluation", "content": "Sputum gram stain and culture are not productive as the samples are often contaminated by oral flora. Blood cultures can be done but are often negative. Today, serology is being used to determine the presence of mycoplasma, legionella, and chlamydia species. PCR is becoming available in most hospitals, but still, the results take 24-48 hours.", "contents": "Pediatric Pneumonia -- Evaluation. Sputum gram stain and culture are not productive as the samples are often contaminated by oral flora. Blood cultures can be done but are often negative. Today, serology is being used to determine the presence of mycoplasma, legionella, and chlamydia species. PCR is becoming available in most hospitals, but still, the results take 24-48 hours."}
{"id": "article-27365_13", "title": "Pediatric Pneumonia -- Evaluation", "content": "There are no clear guidelines for the routine use of chest x-ray in the pediatric population. [24] Although the chest x-ray can be helpful in diagnosis and confirmation of pneumonia, [26] it carries with it risks, including radiation exposure, healthcare-associated costs, and false-negative results, increasing the use of unwarranted antibiotics. Imaging should be restricted to children who appear toxic, those with the recurrent or prolonged course of illness despite treatment, infants ages 0 to 3 months with a fever, suspected foreign body aspiration, or congenital lung malformation. Imaging can also\u00a0be considered in children younger than 5 years old, who present with fever, leukocytosis, and no\u00a0identifiable source of infection. [26] Imaging may also be useful in those with acute worsening of upper respiratory infections or to rule out underlying mass in children who have \"round pneumonia.\" [27] [28]", "contents": "Pediatric Pneumonia -- Evaluation. There are no clear guidelines for the routine use of chest x-ray in the pediatric population. [24] Although the chest x-ray can be helpful in diagnosis and confirmation of pneumonia, [26] it carries with it risks, including radiation exposure, healthcare-associated costs, and false-negative results, increasing the use of unwarranted antibiotics. Imaging should be restricted to children who appear toxic, those with the recurrent or prolonged course of illness despite treatment, infants ages 0 to 3 months with a fever, suspected foreign body aspiration, or congenital lung malformation. Imaging can also\u00a0be considered in children younger than 5 years old, who present with fever, leukocytosis, and no\u00a0identifiable source of infection. [26] Imaging may also be useful in those with acute worsening of upper respiratory infections or to rule out underlying mass in children who have \"round pneumonia.\" [27] [28]"}
{"id": "article-27365_14", "title": "Pediatric Pneumonia -- Treatment / Management", "content": "Treatment should be targeted to a specific pathogen that is suspected based on information obtained from history and physical exam. Supportive and symptomatic management is key and includes supplemental oxygen for hypoxia, antipyretics for fever, and fluids for dehydration. This is especially important for non-infectious pneumonitis and viral pneumonia for which antibiotics are not indicated. [21] [29] Cough suppressants\u00a0are not recommended. If bacterial pneumonia is suspected, treat empirically with antibiotics, keeping in mind significant history and bacterial pathogens that are\u00a0common to specific age groups. Neonates should receive ampicillin plus an aminoglycoside or third-generation cephalosporin [21] [30] ,\u00a0however, not ceftriaxone, as it can displace bound bilirubin and lead to kernicterus. Atypical pneumonia is common in infants 1 to 3 months old, and this group should have additional antibiotic coverage with erythromycin or clarithromycin. [21] [30]", "contents": "Pediatric Pneumonia -- Treatment / Management. Treatment should be targeted to a specific pathogen that is suspected based on information obtained from history and physical exam. Supportive and symptomatic management is key and includes supplemental oxygen for hypoxia, antipyretics for fever, and fluids for dehydration. This is especially important for non-infectious pneumonitis and viral pneumonia for which antibiotics are not indicated. [21] [29] Cough suppressants\u00a0are not recommended. If bacterial pneumonia is suspected, treat empirically with antibiotics, keeping in mind significant history and bacterial pathogens that are\u00a0common to specific age groups. Neonates should receive ampicillin plus an aminoglycoside or third-generation cephalosporin [21] [30] ,\u00a0however, not ceftriaxone, as it can displace bound bilirubin and lead to kernicterus. Atypical pneumonia is common in infants 1 to 3 months old, and this group should have additional antibiotic coverage with erythromycin or clarithromycin. [21] [30]"}
{"id": "article-27365_15", "title": "Pediatric Pneumonia -- Treatment / Management", "content": "For infants and children over 3 months old, S. pneumoniae is the most common, for which the drug of choice is high-dose oral amoxicillin [21] [30] or another beta-lactam antibiotic. In children older than 5 years old, atypical agents have a more important role, and\u00a0macrolide antibiotics are usually first-line therapy. [21]", "contents": "Pediatric Pneumonia -- Treatment / Management. For infants and children over 3 months old, S. pneumoniae is the most common, for which the drug of choice is high-dose oral amoxicillin [21] [30] or another beta-lactam antibiotic. In children older than 5 years old, atypical agents have a more important role, and\u00a0macrolide antibiotics are usually first-line therapy. [21]"}
{"id": "article-27365_16", "title": "Pediatric Pneumonia -- Treatment / Management", "content": "Special attention should be given to children with chronic illnesses, as these might alter choices for antibiotics [21] . Children with sickle cell anemia will need cefotaxime, macrolide,\u00a0vancomycin if severely ill. Children with cystic fibrosis will require piperacillin or ceftazidime plus tobramycin. Treat fulminant viral pneumonia as indicated, depending on the virus identified. For Varicella, use acyclovir and for the respiratory syncytial virus (RSV), use ribavirin for high-risk patients. Patients with HIV should be treated with sulfamethoxazole/trimethoprim and prednisone, and for Cytomegalovirus , ganciclovir and gamma globulin are the preferred agents. If methicillin-resistant Staphylococcus aureus (MRSA) is suspected, clindamycin or vancomycin may be given.", "contents": "Pediatric Pneumonia -- Treatment / Management. Special attention should be given to children with chronic illnesses, as these might alter choices for antibiotics [21] . Children with sickle cell anemia will need cefotaxime, macrolide,\u00a0vancomycin if severely ill. Children with cystic fibrosis will require piperacillin or ceftazidime plus tobramycin. Treat fulminant viral pneumonia as indicated, depending on the virus identified. For Varicella, use acyclovir and for the respiratory syncytial virus (RSV), use ribavirin for high-risk patients. Patients with HIV should be treated with sulfamethoxazole/trimethoprim and prednisone, and for Cytomegalovirus , ganciclovir and gamma globulin are the preferred agents. If methicillin-resistant Staphylococcus aureus (MRSA) is suspected, clindamycin or vancomycin may be given."}
{"id": "article-27365_17", "title": "Pediatric Pneumonia -- Treatment / Management", "content": "It is important to have a high index of suspicion for complications, especially in patients returning for repeat evaluation. For patients sent home with symptomatic or supportive management for suspected viral pneumonia, consider a secondary bacterial infection or other diagnoses upon re-evaluation. [31] Children with uncomplicated bacterial infections who fail to respond to treatment within 72 hours should be assessed for complications, including pneumothorax, empyema, or pleural effusion. [32] Other systemic complications of pneumonia include sepsis, dehydration, arthritis, meningitis, and hemolytic uremic syndrome.", "contents": "Pediatric Pneumonia -- Treatment / Management. It is important to have a high index of suspicion for complications, especially in patients returning for repeat evaluation. For patients sent home with symptomatic or supportive management for suspected viral pneumonia, consider a secondary bacterial infection or other diagnoses upon re-evaluation. [31] Children with uncomplicated bacterial infections who fail to respond to treatment within 72 hours should be assessed for complications, including pneumothorax, empyema, or pleural effusion. [32] Other systemic complications of pneumonia include sepsis, dehydration, arthritis, meningitis, and hemolytic uremic syndrome."}
{"id": "article-27365_18", "title": "Pediatric Pneumonia -- Treatment / Management", "content": "Neonates and infants younger than 90 days old should be hospitalized for treatment, in addition to children who are immunocompromised or have other underlying chronic diseases like sickle cell anemia or cystic fibrosis. [21] Children with social factors that preclude access to care, have failed outpatient therapy, or present with presumed tuberculosis, should also be hospitalized. [33]", "contents": "Pediatric Pneumonia -- Treatment / Management. Neonates and infants younger than 90 days old should be hospitalized for treatment, in addition to children who are immunocompromised or have other underlying chronic diseases like sickle cell anemia or cystic fibrosis. [21] Children with social factors that preclude access to care, have failed outpatient therapy, or present with presumed tuberculosis, should also be hospitalized. [33]"}
{"id": "article-27365_19", "title": "Pediatric Pneumonia -- Treatment / Management", "content": "Admission is often required for patients with respiratory distress and low oxygenation. In most cases, the presence of a parapneumonic effusion requires admission. Children with severe respiratory distress may require chest therapy, CPAP, or even mechanical ventilation. A large pleural effusion requires drainage for diagnostic and therapeutic purposes. In patients with empyema, early video-assisted thoracic surgery (VATS) correlates with decreased mortality, hospital stay, and ionizing radiation from CT scans. It is essential to ensure that clear discharge instructions and return precautions are given to parents or caregivers of children being discharged home in addition to close pediatrician follow-up.", "contents": "Pediatric Pneumonia -- Treatment / Management. Admission is often required for patients with respiratory distress and low oxygenation. In most cases, the presence of a parapneumonic effusion requires admission. Children with severe respiratory distress may require chest therapy, CPAP, or even mechanical ventilation. A large pleural effusion requires drainage for diagnostic and therapeutic purposes. In patients with empyema, early video-assisted thoracic surgery (VATS) correlates with decreased mortality, hospital stay, and ionizing radiation from CT scans. It is essential to ensure that clear discharge instructions and return precautions are given to parents or caregivers of children being discharged home in addition to close pediatrician follow-up."}
{"id": "article-27365_20", "title": "Pediatric Pneumonia -- Differential Diagnosis", "content": "Alveolar proteinosis Aortic stenosis Aseptic meningitis Asphyxiating thoracic dystrophy Aspiration syndromes Asthma Atelectasis AV septal defect, complete AV septal defect, unbalanced Bacteremia Birth trauma", "contents": "Pediatric Pneumonia -- Differential Diagnosis. Alveolar proteinosis Aortic stenosis Aseptic meningitis Asphyxiating thoracic dystrophy Aspiration syndromes Asthma Atelectasis AV septal defect, complete AV septal defect, unbalanced Bacteremia Birth trauma"}
{"id": "article-27365_21", "title": "Pediatric Pneumonia -- Prognosis", "content": "For most children, the prognosis is good. Viral pneumonia tends to resolve without treatment. Long-term sequelae are rare. However, both staphylococcal and varicella pneumonia have guarded outcomes in children.", "contents": "Pediatric Pneumonia -- Prognosis. For most children, the prognosis is good. Viral pneumonia tends to resolve without treatment. Long-term sequelae are rare. However, both staphylococcal and varicella pneumonia have guarded outcomes in children."}
{"id": "article-27365_22", "title": "Pediatric Pneumonia -- Prognosis", "content": "Children with tuberculosis are at high risk for disease progression if the condition is not treated Immunocompromized children have the worst prognosis. Each year, roughly 3 million children die from pneumonia and the majority of these children also have other comorbidities like congenital heart disease, immunosuppression, or chronic lung disease of prematurity.", "contents": "Pediatric Pneumonia -- Prognosis. Children with tuberculosis are at high risk for disease progression if the condition is not treated Immunocompromized children have the worst prognosis. Each year, roughly 3 million children die from pneumonia and the majority of these children also have other comorbidities like congenital heart disease, immunosuppression, or chronic lung disease of prematurity."}
{"id": "article-27365_23", "title": "Pediatric Pneumonia -- Complications", "content": "Empyema Pleural effusion Lung abscess Necrotizing pneumonia Sepsis", "contents": "Pediatric Pneumonia -- Complications. Empyema Pleural effusion Lung abscess Necrotizing pneumonia Sepsis"}
{"id": "article-27365_24", "title": "Pediatric Pneumonia -- Enhancing Healthcare Team Outcomes", "content": "Pediatric pneumonia is often undertreated or missed, leading to high morbidity and mortality. The condition is best managed by an interprofessional team to improve outcomes. The majority of patients are managed by the pediatrician, nurse practitioner, or primary care provider.\u00a0 Patient and caregiver education is vital. Parents need to be told to avoid smoking, and the importance of handwashing cannot be overstated. In addition, all clinicians looking after children should emphasize vaccination against pneumococcus and influenza.", "contents": "Pediatric Pneumonia -- Enhancing Healthcare Team Outcomes. Pediatric pneumonia is often undertreated or missed, leading to high morbidity and mortality. The condition is best managed by an interprofessional team to improve outcomes. The majority of patients are managed by the pediatrician, nurse practitioner, or primary care provider.\u00a0 Patient and caregiver education is vital. Parents need to be told to avoid smoking, and the importance of handwashing cannot be overstated. In addition, all clinicians looking after children should emphasize vaccination against pneumococcus and influenza."}
{"id": "article-27365_25", "title": "Pediatric Pneumonia -- Enhancing Healthcare Team Outcomes", "content": "Healthcare professionals, including physicians, nurses, physician assistants, nurse practitioners, pharmacists, ideally work together in close environments for optimum patient care. When caring for children with pneumonia, pharmacists can be of significant help with geographic resistance patterns for better treatment outcomes with selected antibiotic choices.", "contents": "Pediatric Pneumonia -- Enhancing Healthcare Team Outcomes. Healthcare professionals, including physicians, nurses, physician assistants, nurse practitioners, pharmacists, ideally work together in close environments for optimum patient care. When caring for children with pneumonia, pharmacists can be of significant help with geographic resistance patterns for better treatment outcomes with selected antibiotic choices."}
{"id": "article-27365_26", "title": "Pediatric Pneumonia -- Enhancing Healthcare Team Outcomes", "content": "Caregivers should be educated about signs of respiratory difficulty and when to seek medical assistance. Only through a team approach can pneumonia in children be treated promptly with minimal morbidity.", "contents": "Pediatric Pneumonia -- Enhancing Healthcare Team Outcomes. Caregivers should be educated about signs of respiratory difficulty and when to seek medical assistance. Only through a team approach can pneumonia in children be treated promptly with minimal morbidity."}
{"id": "article-27365_27", "title": "Pediatric Pneumonia -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Pediatric Pneumonia -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}